دورية أكاديمية
أعرض في EDS

Communicative appeals and messaging frames in visual media for HIV pre-exposure prophylaxis promotion to cisgender and transgender women.

التفاصيل البيبلوغرافية
العنوان: Communicative appeals and messaging frames in visual media for HIV pre-exposure prophylaxis promotion to cisgender and transgender women.
المؤلفون: Rosen JG; Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Toomre T; Department of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., To C; Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Olatunde PF; Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Cooper L; Department of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Glick JL; Department of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Park JN; Department of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.; Division of General Internal Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA.; Center for Biomedical Research Excellence on Opioids and Overdose, Rhode Island Hospital, Providence, RI, USA.
المصدر: Culture, health & sexuality [Cult Health Sex] 2023 Aug; Vol. 25 (8), pp. 1007-1023. Date of Electronic Publication: 2022 Sep 08.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 100883416 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-5351 (Electronic) Linking ISSN: 13691058 NLM ISO Abbreviation: Cult Health Sex Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Informa Healthcare
مواضيع طبية MeSH: Pre-Exposure Prophylaxis*/methods , Transgender Persons*/psychology , HIV Infections*/psychology , Anti-HIV Agents*/therapeutic use , Sexual and Gender Minorities*, Male ; Humans ; Female ; Homosexuality, Male/psychology
مستخلص: Women in the USA represent 15% of new HIV diagnoses but only 5% of pre-exposure prophylaxis (PrEP) users. We sought to characterise communicative appeals and messaging frames used in US visual media to cultivate PrEP demand among cisgender and transgender women using content analysis methodology. We catalogued and coded media items (images and videos) from US PrEP marketing campaigns featuring women. Production and content characteristics were abstracted, and communicative appeals from media items were qualitatively coded in duplicate. We then descriptively summarised production and content characteristics and identified discrete subgroups of media items, clustering around specific messaging frames, through qualitative thematic analysis. Racial/ethnic minorities and sexual/gender minority women were heavily featured, and numerous media items leveraged cognitive and social communicative appeals to promote PrEP. We identified three unique messaging frames emerging from coded media items, portraying PrEP as: (1) necessary prevention (protection frame), (2) a desirable yet accessible commodity (aspiration frame), and (3) a conduit to sexual autonomy (empowerment frame). To effectively communicate PrEP information and promote PrEP to women, PrEP marketing should leverage alternative appeals (subjective norms, self-efficacy), address anticipated barriers to uptake (stigma, cost, medication interactions), and deconstruct misconceptions of PrEP use(rs).
References: Subst Use Misuse. 2020;55(14):2409-2419. (PMID: 32962490)
Malar J. 2018 Mar 7;17(1):105. (PMID: 29514698)
Reprod Health. 2022 Apr 7;19(1):92. (PMID: 35392943)
Am J Public Health. 2019 Feb;109(2):289-295. (PMID: 30571295)
AIDS Behav. 2018 Nov;22(11):3627-3636. (PMID: 29589137)
Malar J. 2015 Jan 21;14:15. (PMID: 25603882)
J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):e104-e108. (PMID: 30985557)
MMWR Morb Mortal Wkly Rep. 2018 Oct 19;67(41):1147-1150. (PMID: 30335734)
J Homosex. 2021 Sep 19;68(11):1877-1898. (PMID: 31939710)
Afr J AIDS Res. 2021 Dec;20(4):314-323. (PMID: 34905454)
Cult Health Sex. 2021 Jun;23(6):772-787. (PMID: 32252605)
J Assoc Nurses AIDS Care. 2019 May-Jun;30(3):321-329. (PMID: 30958408)
Cult Health Sex. 2018 Jun;20(6):625-639. (PMID: 28903628)
Health Educ Behav. 2017 Dec;44(6):907-917. (PMID: 28387572)
Glob Health Sci Pract. 2014 Dec 10;2(4):427-43. (PMID: 25611477)
AIDS Behav. 2019 Nov;23(11):2966-2979. (PMID: 31297683)
Soc Sci Med. 2005 Sep;61(5):1026-44. (PMID: 15955404)
BMC Public Health. 2021 Sep 13;21(1):1660. (PMID: 34517875)
J Acquir Immune Defic Syndr. 2020 Aug 15;84(5):497-507. (PMID: 32692108)
AIDS Care. 2018 Oct;30(10):1273-1281. (PMID: 29519143)
PLoS One. 2020 May 4;15(5):e0231155. (PMID: 32365124)
MMWR Morb Mortal Wkly Rep. 2019 May 10;68(18):416-418. (PMID: 31071070)
Cult Health Sex. 2021 Mar;23(3):397-413. (PMID: 32212962)
JAMA. 2020 Jul 28;324(4):395-397. (PMID: 32720996)
JMIR Public Health Surveill. 2018 Feb 16;4(1):e19. (PMID: 29467119)
AIDS Care. 2021 Jun;33(6):721-728. (PMID: 32951438)
J Fam Plann Reprod Health Care. 2005 Jul;31(3):207-12. (PMID: 16105284)
BMC Infect Dis. 2021 Oct 26;21(1):1102. (PMID: 34702165)
Health Commun. 2016 Aug;31(8):998-1007. (PMID: 26756069)
AIDS Behav. 2019 Jul;23(7):1833-1840. (PMID: 30267367)
EClinicalMedicine. 2021 May 15;35:100881. (PMID: 34124631)
BMC Womens Health. 2021 May 25;21(1):220. (PMID: 34034719)
Stud Health Technol Inform. 2019 Aug 21;264:959-963. (PMID: 31438066)
JMIR Public Health Surveill. 2021 Jul 27;7(7):e23876. (PMID: 34061759)
AIDS Behav. 2019 Jul;23(7):1877-1887. (PMID: 30390190)
AIDS Behav. 2011 Jan;15(1):179-85. (PMID: 19636697)
J Womens Health (Larchmt). 2019 Sep;28(9):1272-1285. (PMID: 31180253)
J Acquir Immune Defic Syndr. 2020 Apr 15;83(5):450-456. (PMID: 31939870)
Soc Sci Med. 2000 Jan;50(2):215-31. (PMID: 10619691)
AIDS. 2016 Jul 31;30(12):1973-83. (PMID: 27149090)
JMIR Public Health Surveill. 2019 Jun 17;5(2):e12822. (PMID: 31210141)
Afr J AIDS Res. 2011 Dec;10(4):435-49. (PMID: 25865376)
AIDS Behav. 2020 May;24(5):1312-1333. (PMID: 31807973)
معلومات مُعتمدة: F31 MH126796 United States MH NIMH NIH HHS; P20 GM125507 United States GM NIGMS NIH HHS; P30 AI094189 United States AI NIAID NIH HHS
فهرسة مساهمة: Keywords: Content analysis; HIV prevention; PrEP; health communication; mixed methods research
المشرفين على المادة: 0 (Anti-HIV Agents)
تواريخ الأحداث: Date Created: 20220908 Date Completed: 20230807 Latest Revision: 20230811
رمز التحديث: 20240513
مُعرف محوري في PubMed: PMC9992445
DOI: 10.1080/13691058.2022.2116111
PMID: 36074902
قاعدة البيانات: MEDLINE
الوصف
تدمد:1464-5351
DOI:10.1080/13691058.2022.2116111